BrightSpring Health Analyst Ratings
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $13 From $11.50, Maintains Buy Rating
BrightSpring Health Analyst Ratings
BrightSpring Health Analyst Ratings
Deustche Upgrades BrightSpring to Buy, Cites Valuation
Deutsche Bank Upgrades BrightSpring Health Services to Buy From Hold, $11.50 Price Target
BrightSpring Health Analyst Ratings
Wells Fargo Initiates Brightspring Health Services at Overweight Rating With $15 Price Target
BrightSpring Health Analyst Ratings
No Data